home / stock / allo / allo short
Short Information | Allogene Therapeutics Inc. (NASDAQ:ALLO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 7,364,335 |
Total Actual Volume | 39,867,701 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 368,217 |
Average Short Percentage | 17.81% |
Is there a ALLO Short Squeeze or Breakout about to happen?
See the ALLO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-03-2024 | $3.08 | $3.07 | $3.24 | $3.02 | 1,332,127 | 175,758 | 13.19% |
05-02-2024 | $3.07 | $2.97 | $3.09 | $2.92 | 1,400,492 | 166,469 | 11.89% |
05-01-2024 | $2.78 | $2.92 | $3.029 | $2.74 | 2,585,417 | 359,431 | 13.9% |
04-30-2024 | $2.8 | $2.76 | $2.91 | $2.7 | 2,151,154 | 307,525 | 14.3% |
04-29-2024 | $2.94 | $2.84 | $3.1 | $2.785 | 3,060,517 | 641,065 | 20.95% |
04-26-2024 | $2.87 | $2.89 | $2.93 | $2.75 | 2,452,436 | 569,025 | 23.2% |
04-25-2024 | $2.99 | $2.855 | $2.99 | $2.84 | 2,772,870 | 921,702 | 33.24% |
04-24-2024 | $3.37 | $3.04 | $3.42 | $3.03 | 2,107,578 | 426,978 | 20.26% |
04-23-2024 | $3.41 | $3.37 | $3.53 | $3.36 | 1,606,756 | 205,310 | 12.78% |
04-22-2024 | $3.49 | $3.4 | $3.63 | $3.38 | 1,789,993 | 297,471 | 16.62% |
04-19-2024 | $3.45 | $3.47 | $3.555 | $3.38 | 2,013,218 | 369,549 | 18.36% |
04-18-2024 | $3.52 | $3.46 | $3.56 | $3.45 | 1,245,819 | 170,074 | 13.65% |
04-17-2024 | $3.57 | $3.51 | $3.58 | $3.455 | 2,507,828 | 199,086 | 7.94% |
04-16-2024 | $3.5 | $3.5 | $3.555 | $3.395 | 1,388,064 | 274,125 | 19.75% |
04-15-2024 | $3.86 | $3.55 | $3.88 | $3.535 | 1,592,742 | 353,595 | 22.2% |
04-12-2024 | $3.98 | $3.8 | $4.0062 | $3.74 | 2,882,301 | 432,632 | 15.01% |
04-11-2024 | $4.14 | $3.99 | $4.21 | $3.99 | 2,153,258 | 416,034 | 19.32% |
04-10-2024 | $3.91 | $4.07 | $4.25 | $3.87 | 2,326,913 | 712,081 | 30.6% |
04-09-2024 | $3.99 | $4.11 | $4.11 | $3.93 | 1,368,742 | 223,265 | 16.31% |
04-08-2024 | $3.96 | $3.98 | $4.04 | $3.895 | 1,129,476 | 143,160 | 12.67% |
News, Short Squeeze, Breakout and More Instantly...
Allogene Therapeutics Inc. Company Name:
ALLO Stock Symbol:
NASDAQ Market:
Allogene Therapeutics Inc. Website:
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
$15 million CIRM Grant Supports the Ongoing Phase 1 TRAVERSE Trial Evaluating ALLO-316 in Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC) ALLO-316 Illustrates Proof-of-Concept in RCC and the Potential of Dagger ® Technology to Optimize CAR T Cell Expansion and Pe...
SOUTH SAN FRANCISCO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage biotechnology compan...